While leptin, often upregulated in obesity, has pro-tumorigenic effects by enhancing angiogenesis and cell proliferation, adiponectin, which is reduced in obesity, exhibits anti-inflammatory and anti-tumor properties (30). Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.